サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386206

風疹ワクチンの世界市場：動向、予測、競合分析（～2030年）

Rubella Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

風疹ワクチンの世界市場：動向、予測、競合分析（～2030年）
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

風疹ワクチンの動向と予測

世界の風疹ワクチンの市場規模は、2024～2030年にかけてCAGR 4.1%で成長し、2030年までに約2億4,500万米ドルに達すると予測されています。この市場の主な促進要因は、混合ワクチンに対する需要の高まりと新興諸国における風疹ワクチン接種プログラムの採用率の上昇です。世界の風疹ワクチン市場の将来性は、病院、NGO、小児科クリニック市場における機会によって有望視されています。

風疹ワクチン市場洞察

Lucintelの予測では、麻疹風疹ワクチンは麻疹と風疹を含む2つの伝染性の高い病気から守るために使用されるようになり、予測期間中に最も高い成長が見込まれます。

北米はワクチン接種率が高く、同地域に主要メーカーが存在するため、予測期間中に最も高い成長が見込まれます。

市場規模・推計：風疹ワクチンの市場規模を金額（100万米ドル）で推計

動向と予測分析：各種セグメント別、地域別の市場動向（2018～2023年）と予測（2024～2030年）

セグメンテーション分析：風疹ワクチン市場規模をタイプ別、最終用途別、地域別に金額（100万米ドル）で推

地域別分析：風疹ワクチン市場の北米、欧州、アジア太平洋、その他の地域の内訳

成長機会：風疹ワクチン市場のタイプ別、最終用途別、地域別の成長機会分析

戦略分析：風疹ワクチン市場のM&A、新製品開発、競合情勢など

ポーターのファイブフォースモデルに基づく業界の競合強度分析

本レポートは以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の風疹ワクチン市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の風疹ワクチン市場の動向（2018～2023年）と予測（2024～2030年）
  • 世界の風疹ワクチン市場：タイプ別
    • 一価製剤
    • 麻疹風疹ワクチン
    • 麻疹、おたふく、風疹ワクチン
    • 麻疹、おたふく、風疹水痘ワクチン
  • 世界の風疹ワクチン市場：最終用途別
    • 病院
    • NGO
    • 小児科クリニック
    • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

  • 世界の風疹ワクチン市場：地域別
  • 北米の風疹ワクチン市場
  • 欧州の風疹ワクチン市場
  • アジア太平洋の風疹ワクチン市場
  • その他の地域の風疹ワクチン市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の風疹ワクチン市場の成長機会
    • 最終用途別の世界の風疹ワクチン市場の成長機会
    • 地域別の世界の風疹ワクチン市場の成長機会
  • 世界の風疹ワクチン市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の風疹ワクチン市場の生産能力拡大
    • 世界の風疹ワクチン市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Johnson & Johnson
  • Sanofi Pasteur
  • Bavarian Nordic
  • MedImmune
  • China National Biotec
  • GlaxoSmithKline
  • Pfizer
目次

Rubella Vaccine Trends and Forecast

The future of the global rubella vaccine market looks promising with opportunities in the hospital, NGO, and pediatric clinic markets. The global rubella vaccine market is expected to reach an estimated $245.0 million by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are growing demand for combination vaccines and rising adoption of rubella vaccination programs in developing countries.

A more than 150-page report is developed to help in your business decisions.

Rubella Vaccine by Segment

The study includes a forecast for the global rubella vaccine by type, end use, and region.

Rubella Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monovalent Formulation
  • Measles-Rubella Vaccine
  • Measles, Mumps, Rubella Vaccine
  • Measles Mumps Rubella Varicella Vaccine

Rubella Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • NGO'S
  • Pediatric Clinics
  • Others

Rubella Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Rubella Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rubella vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rubella vaccine companies profiled in this report include-

  • Johnson & Johnson
  • Sanofi Pasteur
  • Bavarian Nordic
  • Medimmune
  • China National Biotec
  • Glaxosmithkline
  • Pfizer

Rubella Vaccine Market Insights

Lucintel forecasts that measles-rubella vaccine is expected to witness highest growth over the forecast period due to it growing usage to protect against two highly contagious diseases including measles and rubella.

North America is expected to witness highest growth over the forecast perioddue to high vaccination coverage rates and presence of key manufacturer in the region.

Features of the Global Rubella Vaccine Market

Market Size Estimates: Rubella vaccine market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rubella vaccine market size by type, end use, and region in terms of value ($M).

Regional Analysis: Rubella vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the rubella vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rubella vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rubella vaccine market size?

Answer: The global rubella vaccine market is expected to reach an estimated $245.0 million by 2030.

Q.2 What is the growth forecast for rubella vaccine market?

Answer: The global rubella vaccine market is expected to grow with a CAGR of 4.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rubella vaccine market?

Answer: The major drivers for this market are growing demand for combination vaccines and rising adoption of rubella vaccination programs in developing countries.

Q4. What are the major segments for rubella vaccine market?

Answer: The future of the rubella vaccine market looks promising with opportunities in the hospital, NGO, and pediatric clinic markets.

Q5. Who are the key rubella vaccine market companies?

Answer: Some of the key rubella vaccine companies are as follows:

  • Johnson & Johnson
  • Sanofi Pasteur
  • Bavarian Nordic
  • Medimmune
  • China National Biotec
  • Glaxosmithkline
  • Pfizer

Q6. Which rubella vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that measles-rubella vaccine is expected to witness highest growth over the forecast period due to it growing usage to protect against two highly contagious diseases including measles and rubella.

Q7. In rubella vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast perioddue to high vaccination coverage rates and presence of key manufacturer in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the rubella vaccine market by type (monovalent formulation, measles-rubella vaccine, measles, mumps, rubella vaccine, and measles mumps rubella varicella vaccine), end use (hospitals, NGO's, pediatric clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rubella Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Rubella Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Rubella Vaccine Market by Type
    • 3.3.1: Monovalent Formulation
    • 3.3.2: Measles-Rubella Vaccine
    • 3.3.3: Measles, Mumps, Rubella Vaccine
    • 3.3.4: Measles Mumps Rubella Varicella Vaccine
  • 3.4: Global Rubella Vaccine Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: NGO's
    • 3.4.3: Pediatric Clinics
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Rubella Vaccine Market by Region
  • 4.2: North American Rubella Vaccine Market
    • 4.2.2: North American Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
  • 4.3: European Rubella Vaccine Market
    • 4.3.1: European Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
    • 4.3.2: European Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
  • 4.4: APAC Rubella Vaccine Market
    • 4.4.1: APAC Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
    • 4.4.2: APAC Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
  • 4.5: ROW Rubella Vaccine Market
    • 4.5.1: ROW Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
    • 4.5.2: ROW Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Rubella Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Rubella Vaccine Market by End Use
    • 6.1.3: Growth Opportunities for the Global Rubella Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Rubella Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Rubella Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rubella Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Johnson & Johnson
  • 7.2: Sanofi Pasteur
  • 7.3: Bavarian Nordic
  • 7.4: MedImmune
  • 7.5: China National Biotec
  • 7.6: GlaxoSmithKline
  • 7.7: Pfizer